EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

High dose soft orthosis for thumb carpometacarpal osteoarthritis in addition to best practice usual care: A feasibility randomised controlled trial

Miranda Bűhler iD, Cathy Chapple iD, Simon Stebbings, G David Baxter

Hand Therapy · 27.04.2026

DOI: 10.1177/17589983261444954 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Hand Therapy, online erschienen am 27.04.2026. Verfasst von Miranda Bűhler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Health, Activity and Rehabilitation Research, School of Physiotherapy, University of Otago, Dunedin, New Zealand. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Otago Medical Research Fund Jack Thomson Arthritis Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Carpometacarpal osteoarthritis (CMC OA) is a common problem in mid-older aged adults. Existing guidelines are ambiguous with respect to materials, design and duration of use of orthoses to manage hand OA. A limitation of studies to date is the low dose (hours per day) of orthosis wearing. This study aimed to evaluate the feasibility of investigating the effectiveness of a soft prefabricated orthosis worn at high dose in conjunction with best practice usual care for CMC OA.

Methods

Study design: Pragmatic, 2-arm parallel-group feasibility RCT. Adults aged ≥40 years with symptomatic CMC OA were randomised to either best practice usual care or usual care in conjunction with a soft neoprene orthosis prescribed to wear 20 h per day, for 4 weeks. A priori feasibility criteria were: (1) enrolment of 30 participants in 4 months; (2) retention >85% at 6 months; (3) intervention adherence on >80% days; (4) interventions acceptable >90% of participants. Outcome measures were collected at baseline, 4 weeks, and 6 months; analysis used descriptive statistics.

Results

Thirty participants were enrolled within 4 months; 97% retained at 6 months. Orthosis wearing achieved ≥20 h on 68% of days. Exercise adherence was 80% on ≥89% of days in both groups. Interventions were acceptable. Clinically significant improvements in pain occurred in both groups.

Discussion

High dose orthosis wearing may be acceptable and feasible for managing CMC OA. Orthosis amendments and a wear target of 18 h are recommended for future investigation of this intervention.

Schlagwörter

Stichwörter der Autor:innen

carpometacarpal jointsfeasibility studiesorthotic devicesosteoarthritisrandomized controlled trials

Autor:innen und Institutionen

  • Centre for Health, Activity and Rehabilitation Research, School of Physiotherapy, University of Otago, Dunedin, New Zealand.
  • Dunedin School of Medicine, Department of Surgical Sciences, University of Otago, Dunedin, New Zealand.

ORCID-Profile: Miranda Bűhler, Cathy Chapple

Förderung

  • Otago Medical Research Fund Jack Thomson Arthritis Fund

Zitieren

APA

Bűhler, M., Chapple, C., Stebbings, S., & Baxter, G. D. (2026). High dose soft orthosis for thumb carpometacarpal osteoarthritis in addition to best practice usual care: A feasibility randomised controlled trial. Hand Therapy. https://doi.org/10.1177/17589983261444954

Vancouver

Bűhler M, Chapple C, Stebbings S, Baxter GD. High dose soft orthosis for thumb carpometacarpal osteoarthritis in addition to best practice usual care: A feasibility randomised controlled trial. Hand Therapy. 2026. doi:10.1177/17589983261444954

BibTeX
@article{Bhler2026,
  author = {Bűhler, Miranda and Chapple, Cathy and Stebbings, Simon and Baxter, G David},
  title = {High dose soft orthosis for thumb carpometacarpal osteoarthritis in addition to best practice usual care: A feasibility randomised controlled trial},
  journal = {Hand Therapy},
  year = {2026},
  doi = {10.1177/17589983261444954}
}
Kostenlos starten →